Vyome (HIND) vs Tempest Therapeutics (TPST)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Vyome (HIND) has outperformed Tempest Therapeutics (TPST) over the past year, losing 67.1% versus a loss of 92.6%. Over five years, TPST leads with a -99.6% price change compared with -100.0% for HIND. Vyome is the larger company by market cap ($14.3 million vs $13.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HIND | TPST |
|---|---|---|
| Share price | $2.04 | $0.7914 |
| Market cap | $14.32M | $13.37M |
| 1-day change | -0.97% | +0.50% |
| YTD return | -40.70% | -72.43% |
| 1-year return | -67.15% | -92.63% |
| 5-year return | -100.00% | -99.59% |
| P/E ratio (TTM) | 1.16 | — |
| EPS (TTM) | $1.76 | $-3.98 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.56 | $12.23 |
| 52-week low | $1.75 | $0.743 |
| Distance from 52-week high | -68.90% | -93.53% |
| Average volume | 13.64K | 2.63M |
| Shares outstanding | 7.02M | 16.89M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HIND has outperformed TPST by 25.5 percentage points over the past year.
HIND vs TPST FAQ
Which is bigger, Vyome or Tempest Therapeutics?
Vyome (HIND) is larger, with a market capitalization of $14.32M compared with $13.37M for Tempest Therapeutics (TPST).
Which stock has performed better over the past year, HIND or TPST?
HIND returned -67.15% over the past 12 months, compared with -92.63% for TPST (price return, excluding dividends). Past performance does not predict future results.
Are Vyome and Tempest Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.